Form D — Ambagon Therapeutics Inc.
0001819934-25-000001 · filed Feb 7, 2025
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Reported offering amount
- $12,000,000
- Reported amount sold
- $5,000,000
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Ambagon Therapeutics Inc.
- CIK
- 1819934
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2020
- Address
- De Lismortel 31, Catalyst Business Ctr
Eindhoven, P7 5612 AR - Phone
- 31 40 7517694
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Melissa McCracken · DirectorEindhoven, P7 Find on LinkedIn ↗
-
Christian Ottmann · Executive OfficerEindhoven, P7 Find on LinkedIn ↗
-
Josh Seidenfeld · Executive OfficerPalo Alto, CA Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗